Close

Analyst Ratings for Myriad Genetics (MYGN) [Buys]

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $23.25 (+8.6%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/14/2023 Guggenheim Subbu Nambi New Coverage Buy
(N/A)
23.00
(N/A)
19.05
(21.40)
12.34% Details
12/13/2023 Wolfe Research Doug Schenkel New Coverage Outperform
(N/A)
N/A
(N/A)
19.05
(21.40)
12.34% Details
Like MYGN Ratings? Also take a look at PSNL, ILMN, QGEN

MYGN Ratings News